We optimized a commercial turbidimetric method for lipase (EC 3.1.1.3) activity (Boehringer Mannheim Diagnostics) and overcame some of its deficiencies. Increasing the bile salt concentration to 35 mmol/L and the colipase concentration to 6 mgfL and using a continuous recording of the reaction-rate curve greatly improved the reaction kinetics, eliminated false results from increases in absorbance, reduced the lag phase, and increased the analytical sensitivity and accuracy. Differentiation of pancreatitis from nonpancreatitis sera by adding NaCI, 140 mmol/L, to the assay mixture to observe the degree of enzyme activation has important limitations. Sera from patients with pancreatitis and only slight or modest increases in lipase behave like sera from healthy individuals or from patients with nonpancreatic disease. The assay shows no interference by lipoprotein lipase and carboxyl esterase. Results compare well by this optimized method and by an optimized "pH-Stat" titrimetric method.
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Although requests to measure the activity of serum lipase (triacylglycerol acylhydrolase, EC 3.1.1.3) in patients with pancreatic disease have increased (1), the test, which is relatively complex, is not as popular as the measurement of serum amylase. Simpler, turbidimetric methods for lipase (2, 3) have been proposed in which a decrease in turbidity, and therefore a decrease in absorbance, of an emulsion is measured as lipase acts to hydrolyze the emulsified substrate. However, these methods are nonspecific, have low sensitivity, and entail difficulties in preparing consistent emulsions. As a further complication, components of some serum specimens may contribute to the turbidity at the beginning of the reaction, and may thus mask some or all of the decrease in absorbance that is due to lipase activity. This phenomenon has been described by Verduin has the advantages of being fast (10 mm) and simple. Unfortunately, however, within the recommended interval of absorbance measurements, some sera still show nonlinear reaction kinetics and increases in absorbance.
We have optimized the reaction system to improve the reaction kinetics and sensitivity, and to reduce the lag phase of the reaction. We have also investigated variousproposals for dealing with the erratic results caused by increases in turbidity: e.g., precipitation of selected proteins with polyethylene glycol (PEG) (9), pretreatment of sera with mercaptoethanol (MCE) (10), and the use of only the linear portions of the reaction-rate curve for calculating lipase activity, regardless of the time when these portions evolve (6, 11). into a 500-mL beaker containing -400 mL of de-ionized water; stir constantly. When the powder is dissolved, transfer the solution to a 500-mL volumetric flaskand fill to the mark with de-ionized water. Store in the dark at 2-8 #{176}C. The solution is stable at least seven weeks if bacterial contamination is avoided.
Materials and Methods

Reagents
Stock colipase solution. Place dried colipase, equivalent to 8.50 mg, into a l0-mL volumetric flask and make up to volume with NaC1, 155 mmol/L. (Note: commercially available colipase has a purity of -60%.) Store in convenient aliquots (e.g., 120 juL) at -70 #{176}C.
Instrumentation
Absorbance measurements were performed in a Model 25 spectrophotometer (Beckman Instruments, Inc., Fullerton, CA 92634). The temperature of the cuvet compartment was controlled electronically at 30 ± 0.1 #{176}C. 
Methods
The BMD turbidimetric assay was carried out as described in the kit insert, except where specified otherwise.
For the pH-Stat procedure, the reaction mixture was modified from that previously published (12) as follows: 7.0 mL of olive oil emulsion, 143 mLIL; 2.8 mL of sodium glycocholate solution, 125 mmol/L, with calcium chloride dihydrate, 30.4 mmol/L; 0.10 mL of colipase solution, 600 mgIL; and 0.10 mL of sample. Hydroxypropyl methylcellulose, 20 g/L, was usedasemulsifier insteadofacacia, and the titrant (NaOH) concentration was changed to 0.0 15 mol/L. The reaction was titrated at pH 9.00. A detailed description of the procedure will be published separately at a later date.
Serum Pretreatment
Pretreatment of serum with PEG (two parts serum and one part of PEG solution, 165 g/L, giving a final PEG concentration of 55 g/L) was carried out as described by Kannisto et al. (9) . The pretreatment with MCE (equal volumes of serum and MCE, 0.2 mollL, giving a final concentration of 0.1 mol/L), was carried out as described by Pope (10) . Mathematical corrections were applied for the dilution of sample as a result of addition of the reagents.
Specimens
"Normal" specimens were taken from healthy laboratory employees who had rested for 20 mm before specimen collection to reduce the effect of hemoconcentration. Other specimens were leftover sera from hospital patients with normal and increased lipase activity. Sera from patients who had rheumatoid factor with titers between 1:40 and 1:160 were identified by the Rheumaton'TM hemagglutination slide test (Wampole Laboratories, Cranbury, NJ 08512). A titer >1:10 is considered positive for this method.
Results and DIscussIon
Linearity of Reaction-Rate Curve
We monitored the reaction-rate curve by using the unmodified BMD kit reagents and sera from healthy adults and hospital patients, including specimens positive for rheumatoid factor. Reactions were monitored until the linearity was filly established; we calculated lipase activity both according to the BMD procedure (using the rate between 4 and 9 mm) and at the time that linearity was fully established. We also calculated the difference between these two values and used the difference as an estimate of the error introduced by use of the unmodified BMD procedure.
We found that most reaction-rate curves showed linear decreases in absorbance, starting at some point between 4
and 9 mm afterinitiation of the reaction; i.e., the curves were not necessarily linear throughout the period specified by the manufacturer for making A readings. All reactionrate curves, however, ultimately showed linear decreases in absorbance if monitored long enough (up to 39 mm). Therefore, following the manufacturer's recommendation for making AA measurements creates the risk of underestimating lipase activity or may even result in negative values. Table 1 , columns A and B, gives the comparative data for the mean activities and ranges (in UIL) observed for measurements taken by using both approaches and BMD reagents. The difference in activity (column B -A) was considered clinically significant if 20 U/L and if near the medical decision level (upper limit of reference range). This difference is also within the precision of the method.
Mean activities and ranges for healthy adults, except for one individual discussed below, were similar, regardless of the approach used for calculating the results. The mean time to reach linearity was 4.8 mm (range 0 to 9 mm). Thus, not all assays with sera from healthy individuals reached linearity within the time period proposed by the manufacturer for making A measurements; however, the associated errors were minimal (<20 U/L) and are probably not of clinical significance. For one healthy individual, however, the lipase value increased by 151% (from 33 to 83 U/L) when the activity was calculated from the linear portionof the reaction-rate curve (instead of during the recommended interval). During the analysis of serum from this individual, the reaction-rate curve did not begin to show a linear decrease in absorbance until 12 mm afterinitiation of the reaction. Much larger differences in activities were seen in a group of seven patients with positive rheumatoid factor and in three other patients with negative rheumatoid factor ( Table  1) . Mean values based on the calculation from the linear portion of the reaction-rate curve (as opposedto those based on the 4-to 9-mm interval) were 163 vs 120 U/L (ranges, 16-630 vs (-)59 to 579 U/L). The mean difference in activity was 44 U/L (range 27-77 U/L). The mean time to reach linearity was 12.6 mm (range 8-30 mm); i.e., none of these samples showed linearity during the entire time period recommended by the manufacturer. We therefore conclude that following the instructions supplied with the BMD kit does not guarantee that specimens will be read during the linear period of change in absorbance, an approach that may introduce unacceptable errors. In the following experiments and recommendations, we have attempted to correct this deficiency by selecting the best of three previously suggested approaches and by recommending modifications in the present reagent composition and procedure. In nearly all cases (33 of 36), PEG treatment of sera The significant agreement of results by all three approaches supports the assumption thatthe linear portion of the reaction-rate curve, even if it occurs afteran initial increase in absorbance, is a good indicator of lipase activity in the specimen. The good correlation between the turbidimetric method (with the modifications described in this paper) and the pH-Stat method, shown later, also supports this conclusion.
Comparison of Approaches to Linearization of the
The lack of full agreement between the threeapproaches for calculating lipase activity may be due to differences in the composition of specimens. The optimal concentration of PEG, for example, differed among specimens; some required higher, some lower concentrations to obtain linearity and optimal activity. Kannisto et al. (9) made similar observations about MCE. Therefore, agreement between these three approaches cannot be expected for all specimens. The unpredictable results obtained with PEG and MCE for some specimens make these two approaches less desirable than monitoring the reaction-rate curve and calculating results from the linear portion of the curve. In addition, thislast approach does not require any pretreatment of the specimen and thus is simpler.
Optimization of Reaction Conditions
Although the data presented above indicate that use of the linear portion of the reaction-rate curve for calculating lipase activity gives improved accuracy, the time required to achieve linearity (up to 39 mm) and the number of specimens that require prolonged monitoring (14% in our sample) are excessive. We therefore attempted to optimize reagents and reaction conditions at 30 #{176}C for an accurate measure of activity in as little time as possible.
Bile salts. Increasing the deoxycholate concentration from 17 mmolJL (as used by the manufacturer) to 25, 30, 35, 40, 50, and 60 mmol/L increased the measured lipase activity.
We founda deoxycholate concentration of 35 mmol/L to be optimal. Although concentrations of 40, 50, and 60 mmolfL resulted in even further increases in lipase activity for many specimens, the reaction kinetics deteriorated for some, with substantial deviations from linearity. There was a marked increase in lipase activity with the use of 35 mmol/L deoxycholate reagent and a reduction in the time required to reach linearity. In the healthy population, the use of 35 instead of 17 mmol/L deoxycholate reagent increased the mean activity from 66 to 85 U/L (29% increase) and shortened the maximum time to reach linearity from 5.5 mm to 2 mm. For the patients for whom there were insignificant differences in activity by the two methods randomly selected subjects. Increasing colipase concentration to 6 mgfL increased the measured lipase activity by as much as 21.0% (ii = 7.1%). Samples with first-measured activities in the range of 220-810 U/L were changed by -2.9% to 6.8% ( = 1.1%). Use of the higher colipase concentration also improved the linear range for some highactivity samples, for which a colipase concentration of 3 mgfL yielded nonlinear reaction-rate curves, apparently because the latter colipase concentrations were inadequate for saturation of the enzyme. However, increases in colipase to 9 and 12 mg/L led to decreases in activity for some patients' samples as well as for the porcine lipase calibrator in the reagent kit. Because colipase in large excesscompetitively inhibits lipase activity (15) , we recommend using a colipase concentration of 6 mgfL.
The beneficial effects of increasing the deoxycholate concentration from 17 mmol/L to 35 mmol/L and increasing the colipase concentration from 3 mg/L to 6 mg/L are obvious from the reaction-rate curves shown in Figure 2 . The initial increase in absorbance observed with this specimen with 0.7 deoxycholate at 17 mmol/L is eliminated by use of the higher concentrations of deoxycholate and colipase; in addition, the measured lipase activity is increased from 89 UIL to 104 U/L. Finally, the lag phase was essentially eliminated for this and nearly all other specimens.
Effect of NaC1 on lipase activity and reaction kinetics. Arzoglou et al. (16) reported that adding solid sodium chloride to the reaction mixture of the BMD kit increased the measured activity and that this increase was affected by both the concentration of the sodium chloride and by the type of lipase isoenzyme present. According to them, increases in activity in sera from healthy individuals and from patients without pancreatitis are greatest at a final NaCl concentration of 80 mmol/L in the reaction mixture, whereas lipase in sera from patients with pancreatitis exhibits the greatest increase in activity in the presence of NaC1, 140 mmol/L. However, they added sodium chloride only to the specimens and not to the calibration standard.
We repeated these experiments with specimens from three healthy individuals, and from six patients with acute pancreatitis, one with chronic pancreatitis, one with chronic renal failure, and one with hepatitis due to acute ethanol intoxication (see Figure 3) . Sodium chloride concentrations of 80 mmolJL in the reaction mixture resulted in the following relative increases: from 1.51 to 2.12 in specimens from healthy individuals, from 1.46 to 3.27 in specimens from individuals with hyperlipasemia due to acute and chronic pancreatitis; and by 1.47 and 2.88 in two patients with hyperlipasemia due to renal disease and ethanol intoxication.
Increasing the NaCl concentration to 140 mmol/L resulted in an additional increase in activity in three specimens from patients with acute pancreatitis who had lipase activities of 633, 3746, and 6623 U/L. We observed a decrease in activity in four specimens, including three from patients with acute pancreatitis (303, 368, 580 U/L) and one from a patient with chronic pancreatitis (157 UIL). We alsonoted decreases, with NaC1 at 140 mmol/L, in two patients with chronic renal disease and ethanol intoxication and in three healthy individuals.
The degree of activation or inhibition apparently depends on the relative mixture of the two lipase isoenzymes present in each specimen, and higher activities at NaCl concentrations of 140 mmolJL occur only if the isoenzyme produced in pancreatitis is present in great excess. As a result, adding NaC1 to the reaction mixture to differentiate pancreatitis from other specimens appears questionable in cases where only slight or moderate increases in lipase are present. The addition of NaC1 to the reaction mixture also causes deterioration of the reaction kinetics and destabilizes the olive oil emulsion. In a forthcoming communication we will describethe failure of NaCl to effect any increase in lipase activity when that activity is measured with a pH-Stat method that is optimized in respect to all reaction parameters, including Ca2. Under these reaction conditions, adding NaCl is not only ineffective but also inhibitory, regardless of the type of specimen used.
A similar optimization of the BMD method in regard to Ca2 is not possible: the use of deoxycholate in this procedure (instead of glycocholate, as in the pH-Stat method) will lead to the formation of precipitates in the reaction mixture if calcium ions are added.
Precision. Resultsof day-to-day and within-day precision studies of the optimized BMD procedure for serum specimens with three concentrations of lipase activity are given in Table 3 . To check for possible interference by lipoprotein lipase, we measured the activity of lipase in serum before and 10 mm afteradministration of 10 units of heparin per kilogram of body weight. In eight individuals tested, lipolytic enzymes released by heparmn caused no measurable differences in activities pre-and post-heparin (P = 0.91). We checked for interference by porcine liver carboxyl esterase by adding 6000 U/L of the enzyme to the reaction mixture; again, we observed no measurable increase in activity. Thus, lipoprotein lipase and porcine liver carboxyl esterase do not seem to interfere with this method. We did observe slight interference from purified human pancreatic carboxyl esterase (EC 3.1.1.1; Mr 300 000); however, this is of no clinical consequence because both enzymes are increased in the same clinical conditions.
Reference Interval
The reference interval for the optimized method was established from results for 113 apparently healthy laboratory employees. Samples were drawn after individuals had rested for at least 20 mm to reduce the effect of hemoconcentration. The central 95 percentiles of results obtained encompassed 30 to 190 U/L ( Figure 5) . As a result of the improved reaction conditions, these values are higher than those we had previously found for the unmodified BMD lipase kit procedure (0 to 150 U/L).
Recommendations
The turbidimetric method as proposed by Neumann et al. (7) and presently marketed by BoehringerMannheim Diagnostics has greatly improved the reliability of turbidimetric measurements of lipase activity; however, the recommended reaction mixture and the fixed time interval for making absorbance readings limit the reliability of the method. Although no serious errors (with one exception) were introduced when lipase activity was measured in serum speci- #{149} Identify the linear portion of the reaction rate curve and calculate results based on a 5-mm segment of this linear portion. This can be achieved by linking the spectrophotometer with a recorder. Alternatively, readings can be made at 1-mm intervals; however, the accuracy and precision of the measurement will deteriorate because of the small absorbance changes observed during 1-mm intervals.
#{149} Run the "standard"supplied with the BMD kit at least once with each substrate vial to compensate for the differences in activity caused by differences in the quality of the emulsified substrate particles, and measure the standard again if the reconstituted substrate is stored for more than one working day. Considerable vial-to-vial variability in the BMD reagents, which has also been observed by Rick and Hockeborn (13), means that measured lipase activity may change if the emulsion is stored overnight.
